The exclusive partnership will bring Sonrai Discovery’s precision medicine capabilities to SmartLabs’ network of managed research centers.
SmartLabs and Sonrai Analytics have announced a global strategic partnership to integrate artificial intelligence (AI) capabilities into SmartLabs’ network of research facilities, potentially accelerating biomarker discovery and diagnostic workflows for member companies.
Under the agreement, SmartLabs will offer Sonrai’s AI analytics platform, Sonrai Discovery, to its member companies across five managed research centers. The partnership will also involve developing exclusive laboratory informatics and AI applications that integrate experimental and infrastructure data to predict scientific outcomes.
Sonrai’s cloud-based platform is designed to help biotech and pharmaceutical teams streamline diagnostic workflows, enhance molecular profiling, and accelerate biomarker discovery by integrating imaging and omics data within a secure ecosystem. The platform enables precision medicine teams to manage complex datasets and identify meaningful patterns for therapeutic development.
“We live in the age of data, and AI is what unlocks its true value,” says Brian Taylor, CEO of SmartLabs, in a release. “I’m excited about this partnership as it allows us to leverage this newfound power to make a profound difference in human health moving forward.”
Expanding Beyond Infrastructure Services
For SmartLabs, which provides flexible laboratory infrastructure and operational services, the partnership represents an expansion beyond traditional facility management into AI-driven research solutions. The company operates managed research centers that allow clients to access enterprise-grade R&D infrastructure without upfront capital investments.
By embedding Sonrai’s analytics capabilities into its facilities, SmartLabs aims to provide member companies with advanced data management tools alongside physical laboratory infrastructure. The exclusive applications developed through the partnership will be available only through SmartLabs’ network.
“At Sonrai, our mission is to power the most important precision medicine breakthroughs through connected data and collaborative science. We are excited to partner with SmartLabs to bring the power of AI and advanced analytics directly to their member companies,” says Darragh McArt, founder and CEO of Sonrai, in a release. “By enabling faster insights and deeper understanding of complex datasets, we help accelerate discoveries and the development of next-generation personalized therapeutics.”
SmartLabs was founded in 2015 and serves biotech, pharmaceutical, and technology organizations across various stages of development. Sonrai Analytics, founded in 2018, focuses on AI applications for precision medicine and partners with biotechnology and pharmaceutical companies for data management and analysis.
ID 132114666 | Ai Integration © Funtap P | Dreamstime.com
